Moclobemide is:
**Core Concept**
Moclobemide is a reversible inhibitor of monoamine oxidase A (RIMA), a class of drugs used in the treatment of depression. This pharmacological action allows for a safer profile compared to traditional MAOIs, as it selectively inhibits the A enzyme, reducing the risk of hypertensive crises.
**Why the Correct Answer is Right**
Moclobemide's mechanism of action involves the inhibition of monoamine oxidase A (MAO-A), an enzyme responsible for the breakdown of monoamines such as serotonin, norepinephrine, and dopamine. By selectively inhibiting MAO-A, moclobemide increases the levels of these neurotransmitters in the synaptic cleft, thereby exerting its antidepressant effects. This selective inhibition also reduces the risk of hypertensive crises seen with non-selective MAOIs.
**Why Each Wrong Option is Incorrect**
**Option A:** Incorrect because moclobemide is not a selective serotonin reuptake inhibitor (SSRI), a different class of antidepressants that increase serotonin levels by blocking its reuptake.
**Option B:** Incorrect because moclobemide is not an atypical antipsychotic, a class of medications primarily used to treat schizophrenia and bipolar disorder.
**Option C:** Incorrect because moclobemide is not a benzodiazepine, a class of anxiolytic medications that act on the GABA receptor.
**Clinical Pearl / High-Yield Fact**
Moclobemide's selective inhibition of MAO-A allows for a safer profile, but it's essential to note that patients taking moclobemide should still avoid certain foods and medications that can interact with the MAO-A enzyme, such as tyramine-rich foods and certain antidepressants.
**Correct Answer: A. Moclobemide is a reversible inhibitor of monoamine oxidase A (RIMA).**